title: Hybrid PET/MR imaging: physics and technical considerations.
abstract: In just over a decade, hybrid imaging with FDG PET/CT has become a standard bearer in the management of cancer patients. An exquisitely sensitive whole-body imaging modality, it combines the ability to detect subtle biologic changes with FDG PET and the anatomic information offered by CT scans. With advances in MR technology and advent of novel targeted PET radiotracers, hybrid PET/MRI is an evolutionary technique that is poised to revolutionize hybrid imaging. It offers unparalleled spatial resolution and functional multi-parametric data combined with biologic information in the non-invasive detection and characterization of diseases, without the deleterious effects of ionizing radiation. This article reviews the basic principles of FDG PET and MR imaging, discusses the salient technical developments of hybrid PET/MR systems, and provides an introduction to FDG PET/MR image acquisition.
authors.affiliation: Section of Abdominal Imaging and Nuclear Radiology, PET/MR Program, Imaging Institute, Cleveland Clinic, 9500 Euclid Avenue, JB-3, Cleveland, OH, 44195, USA, shahs2@ccf.org.
authors.forename: Shetal N
authors.initials: SN
authors.lastname: Shah
authors.forename: Steve S
authors.initials: SS
authors.lastname: Huang
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D064847:Multimodal Imaging / Q000379:methods*; D009369:Neoplasms / Q000473:pathology*; D010825:Physics; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D051598:Whole Body Imaging / Q000379:methods
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18